Sitemap
Pages:
- ADVISORY BOARD
- Advisory Team
- Articles
- Articles 2015
- Articles 2016
- Articles 2017
- Articles 2018
- Articles 2019
- Articles 2020
- ASX 2016
- ASX 2017
- ASX 2018
- ASX 2019
- ASX 2020
- ASX 2021
- Autism Symposium
- BOARD
- CLINICAL TRIALS
- Contact Us
- CORPORATE GOVERNANCE
- Doctors Authentication
- Full Width
- Full Width (Slider)
- Home (Boxed Slider)
- Home (Header 2)
- Home Minamaze
- Home Minamaze
- Image Slider
- Images
- Information for Doctors
- Information for Patients
- Information for Pharmacists
- LEGALISED MARKETS
- LOCATIONS
- Maps
- MARKETS
- MEDIA
- Notification Boxes
- OUR COMPANY
- Page Builder
- Page Options
- Portfolio Projects
- PRECLINICAL
- PRESENTATIONS
- PRESENTATIONS & VIDEOS 2015
- PRESENTATIONS & VIDEOS 2016
- PRESENTATIONS & VIDEOS 2017
- PRESENTATIONS & VIDEOS 2018
- PRESENTATIONS & VIDEOS 2019
- PRESENTATIONS & VIDEOS 2020
- PRESENTATIONS & VIDEOS 2021
- Product Information
- PRODUCT PIPELINE
- Progress Bars
- REPORTS
- SCIENCE
- Service Boxes
- Sitemap
- Slider (Home)
- Slider (Pages)
- Slideshow
- STOCK INFORMATION
- Tabs
- Test
- Toggles
- Video
- Video
- Video + Image
- Video 2017
- Video 2018
- Video on Left
- Video on Right
- Video Slider
- Videos
- VIDEOS
- VIDEOS
- VIDEOS
- VIDEOS
- VIDEOS
- VIDEOS
- VIDEOS
- VIDEOS & AUDIOS
- Zelira Therapeutics Limited Medical Information Disclaimer
Author(s):
Posts:
- Category: articles-2015 (1)
- Category: articles-2016 (9)
- Zelda Therapeutics to Test Formulations against Pancreatic Cancer
- Company Secretary Appointment
- Sleep disorder clinical trials update
- Zelda Therapeutics Enters Into Collaboration Agreement with Prestigious Telethon Kids Institute
- Significant Anti-Cancer Effect Observed in Pre-Clinical Studies
- Zelda Expands Intellectual Property Portfolio
- Zelda Therapeutics debuts on ASX
- Investor Presentation – Nov 2016
- 19 Jan 2016 – Q&A Proactive Investors
- Category: articles-2017 (25)
- Meet Kara: Medical Cannabis & Autism
- ‘Medical Cannabis: The current and future investment market’ – by Dr. Stewart Washer
- Medical Cannabis for Autism
- ASX Announcement: Successful Results in Autism Observation Trial
- ASX Announcement: Update on Research Programme in Chile
- ASX Announcement: Zelda’s Annual Report for the Year Ended 30 June 2017
- ASX Announcement: Company Presentation on 2017 Half Year Activities
- CY Half Year Review 2017
- Cannabis in South America
- Zelda featured in Australian Financial Review
- ASX Announcement: Zelda Expands Breast Cancer Research Collaboration with Complutense
- Breast Cancer and Cannabis Treatments
- ASX Announcement: Zelda enters strategic agreement with Knop Laboratories
- Dr. Stewart Washer talks with Health Professional Radio about recent pre-clinical breast cancer results
- Positive results from pre-clinical breast cancer studies (GIF)
- ASX Announcement: Follow on studies confirm anti-cancer effect in human breast cancer
- Medical Cannabis Therapy for Insomnia
- How medical cannabis can help insomnia?
- Update #2: Our Research Focus (GIF)
- CannaInvestor Webcast Feb/March Issue
- Update #1 by Patty Washer
- What’s all the Fuss About Medical Cannabis?
- CANNAINVESTOR Magazine: Zelda Therapeutics Feature Article
- Interview with Dr Stewart Washer of Zelda Therapeutics – Part 2
- Interview with Dr Stewart Washer of Zelda Therapeutics – Part 1
- Category: articles-2018 (7)
- Prescription Opioid Crisis
- ASX Announcement: Zelda Partners St Vincent’s Hospital on Opioid Reduction Study
- VIRIATHUS RESEARCH REPORT
- Viriathus Research Report
- PAEDIATRIC BRAIN CANCER RESEARCH UPDATE
- ‘Medicinal cannabis: Australia isn’t as progressive as it may seem” – By Dr. Stewart Washer
- ASX Announcement: Shares Begin Trading in the USA on the OTCQB Venture Market
- Category: articles-2019 (6)
- CFN Media Interviews Zelda Therapeutics at New West Summit
- Shareholder Briefing Invitation, Perth
- Forbes Article – Mara Gordon: Aunt Zelda’s, For Every Household
- Zelda Therapeutics – Pioneering Australian Medicinal Cannabis Research
- Zelda Therapeutics to outline cannabinoid-based strategy at Proactive CEO Sessions
- March 2019 Quarterly Report
- Category: articles-2020 (23)
- Australian medicinal cannabis revenue tipped to reach $200 million in 2021 – The West Australian
- 18 Minutes with Zelira Therapeutics – 180 Markets
- The West Australian – Perth family describes their desperation when they sought cannabis for autistic, suicidal son
- OPINION | Reform should be driving protection for medicinal cannabis patients
- Investor buzz around cannabis stocks with new treatments
- Zelira Therapeutics (ASX:ZLD) launches Zenivol in Australia
- Zelira Therapeutics’ insomnia treatment gets TGA tick
- Zelira Therapeutics launches Zenivol™ product in Australia after TGA adds to Special Access Scheme
- Medicinal cannabis trial could help retired AFL players manage chronic pain
- Zelira Therapeutics forms subsidiary to launch hemp-derived oral care products in the USA
- Proactive – Zelira Therapeutics expands US network with Louisiana launch of HOPE products for autism sufferers
- Zelira Therapeutics expands US network with Louisiana launch of HOPE products for autism sufferers
- Zelira Therapeutics MD shows faith in medical cannabis strategy with placement participation
- Proactive – Three medical cannabis companies in focus at Proactive’s webinar on August 11
- Starts at 60 – Suffer from chronic pain? Medicinal cannabis could be the answer
- TechInvest – Zelira obtains key data in cannabis dose escalation study
- The Market Herald – Zelira Therapeutics (ASX:ZLD) confirms ZTL-103 is safe and well-tolerated
- Proactive – Zelira Therapeutics dose escalation trial for chronic pain meets safety and efficacy endpoints
- Stockhead – Pot stock Zelira Therapeutics successfully passes another Phase I clinical trial
- Benzinga Article: A Medicinal Cannabis Company That’s Conducting Clinical Research On Autism, Insomnia, And More
- Q&A with Osagie Imasogie, Chairman, Zelira Therapeutics: Zelira Phase 1b/2a Insomnia Clinical Trial Results
- Biotech Daily – Zelira: Marijuana ZLT-101 ‘Effective For Insomnia’
- Stockhead – Dr Boreham’s Crucible: Zelira’s share price could wake up once sales of its pot-based insomnia drug start
- Category: news (26)
- Australian medicinal cannabis revenue tipped to reach $200 million in 2021 – The West Australian
- 18 Minutes with Zelira Therapeutics – 180 Markets
- Cantor Fitzgerald Hosts Fireside Chat with Zelira Therapeutics
- Medicinal cannabis trial could help retired AFL players manage chronic pain
- Sequoia Initiation Research Report, 19 August 2020
- Proactive – Three medical cannabis companies in focus at Proactive’s webinar on August 11
- Proactive – Zelira Therapeutics dose escalation trial for chronic pain meets safety and efficacy endpoints
- Stockhead – Pot stock Zelira Therapeutics successfully passes another Phase I clinical trial
- Zelira’s Oludare Odumosu, Managing Director USA speaking at More Than A Moment virtual event
- Dr Richard Hopkins, Zelira Therapeutics – 3AW Chronic Pain Interview
- 9 Today – Sleep Drug Jackpot: Is Cannabis oil the answer to insomnia?
- Zelira’s Dr Richard Hopkins, Managing Director – ex USA will be presenting on the 2 June, 2pm AEST at the 2020 Finance News Network CEO Showcases
- Benzinga Article: A Medicinal Cannabis Company That’s Conducting Clinical Research On Autism, Insomnia, And More
- Dr Richard Hopkins, Zelira Therapeutics – Triple M Great Southern WA
- Cannaweek Podcast, 05 May 2020
- Review of Zelira’s Insomnia Clinical Trial by Paul Mavor, Health House International Pty Ltd
- Q&A with Osagie Imasogie, Chairman, Zelira Therapeutics: Zelira Phase 1b/2a Insomnia Clinical Trial Results
- Zelira’s Medicinal Cannabis Insomnia Clinical Trial on Channel 10 News First
- Biotech Daily – Zelira: Marijuana ZLT-101 ‘Effective For Insomnia’
- Investor Teleconference: Insomnia Trial Meets Primary and Secondary Endpoints
- Stockhead – Dr Boreham’s Crucible: Zelira’s share price could wake up once sales of its pot-based insomnia drug start
- CFN Media Interviews Zelda Therapeutics at New West Summit
- Autism Symposium
- Forbes Article – Mara Gordon: Aunt Zelda’s, For Every Household
- Zelda Therapeutics – Pioneering Australian Medicinal Cannabis Research
- Zelda Therapeutics to outline cannabinoid-based strategy at Proactive CEO Sessions
- Category: report (2)
- Category: Uncategorized (1)
- Category: video-2020 (4)
Archives:
- April 2021 (1)
- December 2020 (1)
- November 2020 (2)
- October 2020 (1)
- September 2020 (6)
- August 2020 (5)
- July 2020 (5)
- June 2020 (3)
- May 2020 (4)
- April 2020 (5)
- March 2020 (1)
- October 2019 (2)
- June 2019 (1)
- May 2019 (3)
- April 2019 (1)
- January 2019 (1)
- November 2018 (2)
- September 2018 (2)
- June 2018 (1)
- February 2018 (1)
- January 2018 (1)
- December 2017 (1)
- September 2017 (4)
- August 2017 (5)
- July 2017 (2)
- June 2017 (4)
- May 2017 (3)
- March 2017 (4)
- January 2017 (2)
- December 2016 (4)
- November 2016 (4)
- January 2016 (1)
- December 2015 (1)